The BD PhaSeal™ Injector attaches a syringe to the BD PhaSeal drug vial access device on a drug vial, or a syringe to BD PhaSeal IV line access devices on IV tubing—forming dry, leak-proof connections during drug preparation and administration.
The BD PhaSeal™ Injector attaches a syringe to the BD PhaSeal drug vial access device on a drug vial, or a syringe to BD PhaSeal IV line access devices on IV tubing—forming dry, leak-proof connections during drug preparation and administration.
GTIN - Case
50382905150031
200
GTIN - Shelfpack
30382905150037
50
GTIN - each
00382905150036
1
NHRIC No.
8290-5150-03
Syringe Barrel Material
Polypropylene; Acrylonitrile-butadiene-styrene copolymer
Dimensions
71 mm x 17 mm
Volume
0.04 mL
Cannula Material
Stainless steel
Membrane
Thermoplastic elastomer
Material
Not reusable; PVC free; DEHP free; BPA free; latex free; sterilized using ethylene oxide
GTIN - Case | 50382905150031 | 200 |
GTIN - Shelfpack | 30382905150037 | 50 |
GTIN - each | 00382905150036 | 1 |
NHRIC No. | 8290-5150-03 |
Syringe Barrel Material | Polypropylene; Acrylonitrile-butadiene-styrene copolymer |
Dimensions | 71 mm x 17 mm |
Volume | 0.04 mL |
Cannula Material | Stainless steel |
Membrane | Thermoplastic elastomer |
Material | Not reusable; PVC free; DEHP free; BPA free; latex free; sterilized using ethylene oxide |
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
If you are a patient or end user, you can contact us yourself, or you may have your caregiver or your physician do that for you. To help us process your
information quickly and effectively, please contact our customer complaints
team.
To better facilitate our investigation, please include the following information in your reporting: